
India has long been an important part of the global pharmaceutical industry, particularly in the manufacturing and supply of medicines. Now, the country is investing in another critical part of pha...

When a frozen or chilled box arrives at a customer’s door, the judgement happens fast. Before the product is tasted, the experience is already being scored. From the inside, it is tempting to tre...

Operating from one of the most geographically isolated developed markets in the world has always required a different relationship with supply. I.e. distance is not an exception to manage; it is th...

Most brands don’t outgrow their product; they outgrow their systems.

Cold chain systems are often designed under ideal assumptions; however, the reality of shipments can differ dramatically from the validation process.

Growth from 500 boxes a week to 5,000 rarely fails because demand disappears; it stalls because the system underneath was never designed to carry that load. At lower volumes, small inefficiencies ...

Thermal validation is often viewed as a pass or fail exercise. A packaging system either maintains temperature for the required duration or it does not. While that outcome matters, it only tells pa...

New healthcare air corridors, planned cold-chain facilities and regional manufacturing investment are expanding pharmaceutical distribution options across Asia. This article examines what these dev...

Insulin made peptide medicines part of everyday healthcare long before semaglutide and tirzepatide became familiar names. What the growth of GLP-1-based therapies has changed is the commercial scal...
